Veralipride

CHEMBL2105581 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

383.5 g/mol

LogP

0.8

Phase

4

Veralipride is a substituted benzamide antidopaminergic agent that blocks dopamine D2 receptors, developed for the management of menopausal hot flashes as an alternative to hormone replacement therapy. It was withdrawn in several countries due to adverse neurological effects including tardive dyskinesia and other extrapyramidal symptoms associated with its dopamine antagonist mechanism. Its use demonstrated the role of dopaminergic pathways in thermoregulation.

분자량

383.5000 g/mol

LogP

0.80

TPSA

119.00 Å²

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC

InChI

InChI=1S/C17H25N3O5S/c1-4-7-20-8-5-6-12(20)11-19-17(21)14-9-13(26(18,22)23)10-15(24-2)16(14)25-3/h4,9-10,12H,1,5-8,11H2,2-3H3,(H,19,21)(H2,18,22,23)

Molecular Formula

C17H25N3O5S

HBD / HBA

2 / 7

회전 가능 결합

8

무거운 원자

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Veralipride is a substituted benzamide antidopaminergic agent that blocks dopamine D2 receptors, developed for the management of menopausal hot flashes as an alternative to hormone replacement therapy. It was withdrawn in several countries due to adverse neurological effects including tardive dyskinesia and other extrapyramidal symptoms associated with its dopamine antagonist mechanism. Its use demonstrated the role of dopaminergic pathways in thermoregulation.

Yes, Veralipride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105581. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 47979. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Veralipride PillFYI에서

구조

핵심 데이터

분자식: C17H25N3O5S

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.